209
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA

, &
Pages 1443-1450 | Received 21 Apr 2013, Accepted 05 Jul 2013, Published online: 21 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yanping Sun, Lei Xian, Haonan Xing, Jiankun Yu, Zhen Yang, Tianzhi Yang, Li Yang & Pingtian Ding. (2016) Factors influencing the nuclear targeting ability of nuclear localization signals. Journal of Drug Targeting 24:10, pages 927-933.
Read now
Hong Jiang, Dongming Geng, Hongqia Liu, Zhengrong Li & Jing Cao. (2016) Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Drug Delivery 23:9, pages 3665-3673.
Read now
Yanan Li, Junling Zhang, Buhai Wang, Yan Shen & Ammar Ouahab. (2016) Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles. Drug Development and Industrial Pharmacy 42:5, pages 737-746.
Read now

Articles from other publishers (3)

Adeel Masood Butt, Nabiha Abdullah, Nur Najihah Izzati Mat Rani, Naveed Ahmad & Mohd Cairul Iqbal Mohd Amin. (2022) Endosomal Escape of Bioactives Deployed via Nanocarriers: Insights Into the Design of Polymeric Micelles. Pharmaceutical Research 39:6, pages 1047-1064.
Crossref
Maria Abdul Ghafoor Raja, Haliza Katas & Muhammad Wahab Amjad. (2019) Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA. Asian Journal of Pharmaceutical Sciences 14:5, pages 497-510.
Crossref
Khaled Messaoudi, Anne Clavreul, Fabienne Danhier, Patrick Saulnier, Jean-Pierre Benoit & Frederic Lagarce. (2015) Combined silencing expression of MGMT with EGFR or galectin-1 enhances the sensitivity of glioblastoma to temozolomide. European Journal of Nanomedicine 7:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.